Assessment of methadone treatments in Andalusia (ETMA). Results from the pilot study
DOI:
https://doi.org/10.20882/adicciones.575Keywords:
methadone, programme assessment, retentionAbstract
Objective: The aim of this project is to assess methadone treatments in Andalusia. This paper introduces some of the results of the pilot study. Methods: Retrospective review of a sample of 60 patients admitted for treatment from 1/1/98 in three Provincial Drug Dependency Centres. Results: To estimate the principal outcome variable – the retention rate – two criteria were used to define censored and events. Thus, two survival curves were achieved which showed retention at 18 months of 75% and 53.3% respectively. Conclusions: The results of the use patterns and serological state in respect of HIV are positively evaluated. The difference between the survival curves (21.7%) shows the importance of the criteria used to define censored and event cases in the main variable to determine the success/failure of a Methadone Treatment Programme. Even so, the retention observed supports the perception of a good ability of these treatments in Andalusia to retain their patients. However, we must wait for the final results. The high percentages of “unknown” data suggest important deficiencies in the level of knowledge that can be obtained as well as the possibility of carrying out continuous assessments with retrospective information.References
Junta de Andalucía. Consejería de Trabajo y Asuntos Sociales. Consejería de Salud, Comisionado para la Droga Programa de Mantenimiento con Metadona en Andalucía. Manual de Orientación. Junta de Andalucía. 1996.
Observatorio Español sobre Drogas Informe Nº2. pp 52-53. Ed: Ministerio del Interior. Delegación del Gobierno para el Plan Nacional sobre Drogas. Secretaría General Técnica. 1999.
Junta de Andalucía, Consejería de Asuntos Sociales,
Comisionado para la Droga Los Andaluces ante las Drogas. IV. pp 115-119. Junta de Andalucía. Investigación y Estudios IV. 1994.
Asesoría EASP Evaluación del Plan Andaluz sobre Drogas
Asesoría EASP para el Comisionado para las Drogodependencias.
Caplehorn JRM.; Dalton MSYN.; Haldar F.; Petrenas AM.; y Nisbet JG. Methadone maintenance and addicts’ risk of fatal heroin overdose. Substance Use & Misuse, 1996, 31 (2) 177-196.
Baker A.; Kochan N.; Dixon J.; et al. HIV risk-taking behaviour among injecticg drug users currently, previously
and never enrrolled in methadone treatment. Addiction, 1995, 90, 545-554.
French M.T.; Zarkin GA.; Hubbard EL.. y Rachal JV. The
effects of time in drug abuse treatment and employement on post-treatment drug use and criminal activity. American Journal of Drug and Alcohol Abuse, 1993, 19, 19-33.
Magura S.; Nwakeze PC. y Demsky S. Pre- and in-treatment
predictors of retention in methadone treatment using survival analysis. Addiction, 1998, 93 (1), 51-60.
Simpson DD.; Joe GW.; y Rowan-Szal G. Drug abuse
treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence, 1997, 47, 227-235.
D’Ippoliti D.; Davoli M.; Perucci A..; Pasqualini F. y Bargagli
AM. Retention in treatment of heroin users in italy: the role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependence, 1998, 52, 167-171.
Torrens M.; Castillo C. y Pérez-Solà V. Retention in a lowthreshold methadone maintenance program. Drug and
Alcohol Dependence, 1996, 41, 55-59.
McLellan AT.; Arndt IO.; Metzger DS.; Woody GE. y
O’Brien CH. The effects of psychosocial services in substance abuse treatment. JAMA, 1993, 269 (15) 1953-1959.
Ball JC.; y Ross A.. The effectiveness of Methadone
Maintenance Treatment. New York, Springer-Verlag, 1991.
Del Rio M.; Mino A. y Perneger TV. Predictors of Patient
Retention in a Newly Established Methadone Treatment Programme. Addiction, 1997, 92 (10), 1353-1360.
Lee ET. Statistical Methods for Survival Data Analysis.
New York, Wiley. 1992.
Kaplan EL y Meier P. Nonparametric estimation from
incomplete observations. J. Am. Stat. Assoc. 1958, 53, 457-481.
Perea-Milla E. Tipos de estudio. En: Metodología de
investigación y escritura científica en clínica. Parte 1. A. Editor: Burgos Rodríguez R. Escuela Andaluza de Salud Pública. 1998.
Delegación del Gobierno para el Plan Nacional sobre Drogas. Observatorio Español sobre Drogas. Encuesta a Consumidores de Heroína en tratamiento (ECHT) 1996/7. En: "Informe Nº1" DGPNSD, Ministerio del Interior; 1998.
Delegación del Gobierno para el Plan Nacional sobre
Drogas. Observatorio Español sobre Drogas Informe nº 3 Marzo 2.000. DGPNSD, Ministerio del Interior. 2000.
Kreek MJ. Using methadone effectively: achieving goals
by application of laboratory, clinial, and evaluation research
and by development of innovative programs. En: Improving Drug Abuse Treatment (Pickens R.W., Leukfeld, C.G. and Schuster, Ch. R., eds.) pp 2445-266. National Institute on Drug Abuse Research Monograph Series. Rockville. 1991.
